High-throughput 3D engineered paediatric tumour models for precision medicine

Precision medicine for paediatric and adult cancers that incorporates drug sensitivity profiling can identify effective therapies for individual patients. However, obtaining adequate biopsy samples for high-throughput (HTP) screening remains challenging, with tumours needing to be expanded in culture or patient-derived xenografts, this is time-consuming and often unsuccessful. Herein, we have developed paediatric patient-derived tumour models using an engineered extracellular matrix (ECM) tissue mimic hydrogel system and HTP 3D bioprinting. Gene expression analysis from a neuroblastoma and sarcoma paediatric patient cohort identified key components of the ECM in these tumour types. Engineered hydrogels with ECM-mimic peptides were used to bioprint and create patient-specific tumouroids using patient-derived cells from xenograft models, and the approach was further confirmed on direct patient tumour samples. Bioprinted tumouroids from the PDX models recapitulated the genetic and phenotypic characteristics of the original tumours and retained tumourigenicity. HTP drug screening of these models identified individualised drug sensitivities. Our approach offers a timely and clinically relevant technology platform for precision medicine in paediatric cancers, potentially transforming preclinical testing across multiple cancer types.

Authors

Institutions

Publication Details

Journal
Molecular Systems Biology
Published
2025-10-01
DOI
https://doi.org/10.1038/s44320-025-00152-y
Primary Topic
3D Printing in Biomedical Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

High-throughput 3D engineered paediatric tumour models for precision medicine

Kathleen Kimpton, Joanna N. Skhinas, Emmy D.G. Fleuren, Angela Lin et al.
Molecular Systems Biology
3D Printing in Biomedical Research
article

High-throughput 3D engineered paediatric tumour models for precision medicine

Kathleen Kimpton, Joanna N. Skhinas, Emmy D.G. Fleuren, Angela Lin, Alvin Kamili, Gábor Tax, Philipp Graber, Maria Kavallaris, Jinhan Xie, M. Emmy M. Dolman, MoonSun Jung, Marie Wong, J. Justin Gooding, John P. Grady, Chelsea Mayoh, Andrew J. Gifford, Loretta M. S. Lau, David M. Thomas, Ashleigh M. Fordham, Pooja Venkat, Mark J. Cowley, Lujing Cui, Jie Mao, Sarah Ghamrawi, Nicole Graf, Jamie I. Fletcher, Eric Y. Du, Zara Barger, Valentina Poltavets
article en

Abstract

Precision medicine for paediatric and adult cancers that incorporates drug sensitivity profiling can identify effective therapies for individual patients. However, obtaining adequate biopsy samples for high-throughput (HTP) screening remains challenging, with tumours needing to be expanded in culture or patient-derived xenografts, this is time-consuming and often unsuccessful. Herein, we have developed paediatric patient-derived tumour models using an engineered extracellular matrix (ECM) tissue mimic hydrogel system and HTP 3D bioprinting. Gene expression analysis from a neuroblastoma and sarcoma paediatric patient cohort identified key components of the ECM in these tumour types. Engineered hydrogels with ECM-mimic peptides were used to bioprint and create patient-specific tumouroids using patient-derived cells from xenograft models, and the approach was further confirmed on direct patient tumour samples. Bioprinted tumouroids from the PDX models recapitulated the genetic and phenotypic characteristics of the original tumours and retained tumourigenicity. HTP drug screening of these models identified individualised drug sensitivities. Our approach offers a timely and clinically relevant technology platform for precision medicine in paediatric cancers, potentially transforming preclinical testing across multiple cancer types.

Molecular Systems BiologyVol. 21(12)
The University of Sydney (AU), New South Wales Department of Health (AU), Garvan Institute of Medical Research (AU), Cancer Institute of New South Wales (AU), Children's Hospital at Westmead (AU), Westmead Hospital (AU), UNSW Sydney (AU), Prince of Wales Hospital (AU), Children's Cancer Institute Australia (AU), Melanoma Institute Australia (AU), St Vincent's Clinic (AU), Sydney Children's Hospital (AU), Princess Máxima Center (NL), Westmead Institute (AU)
Openalex Percentile: Top 74%
3D Printing in Biomedical Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.